Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, as monotherapy in epidermal growth factor receptor (EGFR) amplified, recurrent glioblastoma (GBM)

The requested reference [87702c0c442157f91752a2d2aea18f51de4da4aa] no longer exists in our database. It has been replaced by the current reference: [9e495dab46c7013708c88b2723ea1098ed48fb74]

Authors
Category Primary study
JournalNeuro-Oncology
Year 2016
This article has no abstract
Epistemonikos ID: 9883346d14b181ce7cc81cb4fa5c2dd3e03d9908
First added on: Feb 08, 2025